Congcong Sun
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 8
- Protein Degradation and Inhibitors 3
-
- Vitamin D Research Studies 3
- Co-authors
- Mark K. Bennett (8 shared papers)Kevin D. Shenk (7 shared papers)Susan D. Demo (8 shared papers)Fijs W. B. van Leeuwen (1 shared paper)Asher Chanan‐Khan (1 shared paper)Peter M. Voorhees (2 shared papers)Deborah J. Kuhn (2 shared papers)Robert Z. Orlowski (2 shared papers)
- Journals
- Blood (7 papers)Medicine (2 papers)Frontiers in Pharmacology (2 papers)BMC Plant Biology (1 paper)International Journal of Industrial Engineering Computations (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Congcong Sun
51 papers receiving 1.8k citations
Congcong Sun's Hit Papers
Peers
Comparison fields: 5 of 120
- Hematology 558
- Oncology 415
- Molecular Biology 1.1k
- Genetics 99
- Toxicology 26
Countries citing papers authored by Congcong Sun
This map shows the geographic impact of Congcong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congcong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congcong Sun more than expected).
Fields of papers citing papers by Congcong Sun
This network shows the impact of papers produced by Congcong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congcong Sun. The network helps show where Congcong Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Congcong Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma Hit paper breakdown → | 2007 | 615 |
| 2 | Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome Hit paper breakdown → | 2007 | 567 |
| 3 | 2020 | 103 | |
| 4 | 2020 | 96 | |
| 5 | 2017 | 57 | |
| 6 | 2019 | 35 | |
| 7 | 2016 | 34 | |
| 8 | 2016 | 31 | |
| 9 | 2021 | 28 | |
| 10 | 2000 | 20 | |
| 11 | 2022 | 17 | |
| 12 | 1998 | 16 | |
| 13 | 2019 | 15 | |
| 14 | 2022 | 15 | |
| 15 | 2021 | 13 | |
| 16 | 2005 | 13 | |
| 17 | 2020 | 12 | |
| 18 | 2020 | 11 | |
| 19 | 2023 | 10 | |
| 20 | 2025 | 9 |
About Congcong Sun
Congcong Sun is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Plant Science and Cancer Research, having authored 58 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Multiple Myeloma Research and Treatments (4 papers), Peptidase Inhibition and Analysis (4 papers), Vitamin D Research Studies (3 papers), Gestational Diabetes Research and Management (3 papers), Protein Degradation and Inhibitors (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Birth, Development, and Health (3 papers). The work is most often cited by research in Hematology (558 citations), Oncology (415 citations), Molecular Biology (1.1k citations), Genetics (99 citations) and Toxicology (26 citations). Congcong Sun has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Mark K. Bennett, Kevin D. Shenk, Susan D. Demo, Fijs W. B. van Leeuwen, Asher Chanan‐Khan, Peter M. Voorhees, Deborah J. Kuhn, Robert Z. Orlowski, Qing Chen and John S. Strader. Their work appears in journals such as Blood, Medicine, Frontiers in Pharmacology, BMC Plant Biology and International Journal of Industrial Engineering Computations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.